TVGN · Tevogen Inc. · Documents

May 28

Quarterly report 10-Q FY2024 Q1, ended Mar 31

Quarterly report for FY2024 Q1

Net income $11.26M Diluted EPS -$0.26

May 16

Current report 8-K Events of May 10

Entered into a material agreement

May 16

Late filing notice NT 10-Q

Late filing notice

May 2

Current report 8-K Events of Apr 29

Change of auditor

Apr 29

Current report 8-K/A Events of Feb 14

Current report

Apr 29

Annual report 10-K FY2023, ended Dec 31

Annual report for FY2023

Net loss $67.33K

Apr 26

Current report 8-K

Financial results

Apr 10

Current report 8-K/A Events of Mar 27

Entered into a material agreement, Unregistered sale of equity, Charter or bylaw amendment, or fiscal year change

Apr 2

Current report 8-K Events of Mar 27

Entered into a material agreement, Charter or bylaw amendment, or fiscal year change

Apr 2

Late filing notice NT 10-K

Late filing notice

Mar 21

Current report 8-K Events of Mar 15

Charter or bylaw amendment, or fiscal year change

Feb 21

Current report 8-K Events of Feb 14

Code of ethics change or waiver

Feb 20

Current report 8-K/A Events of Feb 14

Entered into a material agreement, Unregistered sale of equity, Other events

Feb 14

Current report 8-K

Entered into a material agreement, Completed an acquisition or sale of assets, Unregistered sale of equity, Change to shareholders' rights, Change in control, Director or officer change, or executive pay, Charter or bylaw amendment, or fiscal year change, Change in shell company status

Feb 1

Current report 8-K Events of Jan 31

Shareholder vote results, Regulation FD disclosure

Jan 24

Current report 8-K

Regulation FD disclosure

Jan 5

Current report 8-K Events of Jan 4

Regulation FD disclosure

Dec 22

Registration statement S-4/A

Registration statement

Dec 19

Current report 8-K/A Events of Dec 14

Change to shareholders' rights, Charter or bylaw amendment, or fiscal year change, Shareholder vote results, Other events

Dec 18

Current report 8-K Events of Dec 14

Change to shareholders' rights, Charter or bylaw amendment, or fiscal year change, Shareholder vote results, Other events

Dec 13

Proxy statement DEFR14A

Proxy statement

Dec 4

Proxy statement DEF 14A

Proxy statement

Nov 22

Registration statement S-4/A

Registration statement

Nov 17

Current report 8-K

Regulation FD disclosure

Nov 13

Quarterly report 10-Q FY2023 Q3, ended Sep 30

Quarterly report for FY2023 Q3

Net loss $278.75K

Nov 13

Proxy statement PRE 14A

Proxy statement

Oct 23

Quarterly report 10-Q/A Ended Jun 30

Quarterly report for the period ended Jun 30, 2023

Oct 23

Registration statement S-4/A

Registration statement

Sep 29

Current report 8-K Events of Sep 28

Other events

Sep 14

Current report 8-K

Regulation FD disclosure

Sep 14

Registration statement S-4

Registration statement

Aug 21

Quarterly report 10-Q FY2023 Q2, ended Jun 30

Quarterly report for FY2023 Q2

Net loss $195.06K

Aug 15

Late filing notice NT 10-Q

Late filing notice

Jun 29

Current report 8-K Events of Jun 28

Entered into a material agreement, Regulation FD disclosure

Jun 7

Current report 8-K

Entered into a material agreement, Director or officer change, or executive pay

May 22

Quarterly report 10-Q FY2023 Q1, ended Mar 31

Quarterly report for FY2023 Q1

Net income $1.24M

May 15

Late filing notice NT 10-Q

Late filing notice

May 9

Current report 8-K Events of May 4

Entered into a material agreement, Delisting notice or listing transfer

Apr 17

Annual report 10-K FY2022, ended Dec 31

Annual report for FY2022

Net income $4.41M

Apr 7

Current report 8-K Events of Apr 4

Delisting notice or listing transfer

Mar 31

Late filing notice NT 10-K

Late filing notice

Mar 29

Current report 8-K Events of Mar 23

Delisting notice or listing transfer

Feb 9

Current report 8-K Events of Feb 3

Charter or bylaw amendment, or fiscal year change, Shareholder vote results

Jan 31

Current report 8-K Events of Jan 30

Other events

Jan 26

Current report 8-K

Other events

Jan 26

Proxy statement DEFA14A

Proxy statement

Jan 20

Proxy statement DEF 14A Meeting Feb 3, 2023

Proxy statement

Jan 10

Proxy statement PRE 14A

Proxy statement

Nov 14

Quarterly report 10-Q FY2022 Q3, ended Sep 30

Quarterly report for FY2022 Q3

Net income $1.61M

Aug 15

Quarterly report 10-Q FY2022 Q2, ended Jun 30

Quarterly report for FY2022 Q2

Net income $207K